| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Technetium Tc 99m tilmanocept | NEO3-09 | Approved | University Of California | Lymphoseek Kit, Lymphoseek, Lymphoaim | United States | Solid tumours; Head and Neck Neoplasms; Melanoma; Carcinoma, Squamous Cell; Breast Neoplasms; Diagnostic agents | Cardinal Health 414 Llc | 2013-03-13 | Arthritis, Rheumatoid; Uterine Cervical Neoplasms; Sarcoma, Kaposi; Melanoma; Endometrial Neoplasms; Diagnostic agents; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Liver Neoplasms; Colonic Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Metabolic Dysfunction-Associated Steatotic Liver Disease; Head and Neck Neoplasms; Solid tumours; HIV Infections | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



